IRIS
TOSCO, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.392
NA - Nord America 1.148
EU - Europa 1.004
SA - Sud America 179
AF - Africa 41
OC - Oceania 1
Totale 3.765
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.086
SG - Singapore 606
RU - Federazione Russa 449
VN - Vietnam 343
CN - Cina 247
IT - Italia 222
BR - Brasile 141
HK - Hong Kong 86
DE - Germania 75
NL - Olanda 73
FI - Finlandia 48
FR - Francia 46
CA - Canada 41
CI - Costa d'Avorio 24
GB - Regno Unito 22
IE - Irlanda 19
MX - Messico 16
AR - Argentina 15
JP - Giappone 15
BD - Bangladesh 12
ES - Italia 10
KR - Corea 10
AT - Austria 9
EC - Ecuador 9
IQ - Iraq 8
TR - Turchia 8
UA - Ucraina 8
ID - Indonesia 7
IN - India 7
PH - Filippine 7
SK - Slovacchia (Repubblica Slovacca) 7
TH - Thailandia 7
ZA - Sudafrica 7
SE - Svezia 6
CO - Colombia 4
JO - Giordania 4
TW - Taiwan 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
OM - Oman 3
PL - Polonia 3
PY - Paraguay 3
VE - Venezuela 3
CL - Cile 2
KE - Kenya 2
PK - Pakistan 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
LB - Libano 1
LU - Lussemburgo 1
MG - Madagascar 1
ML - Mali 1
MN - Mongolia 1
PA - Panama 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
YE - Yemen 1
Totale 3.765
Salva come PNG Salva come JPEG
Città #
Singapore 273
San Jose 189
Chandler 111
Ashburn 107
Moscow 102
Ho Chi Minh City 84
Beijing 80
Hong Kong 80
Naples 79
Hanoi 68
Amsterdam 66
Santa Clara 54
The Dalles 43
Napoli 39
Hefei 35
Munich 35
Los Angeles 30
Lauterbourg 26
Haiphong 20
Turku 20
Da Nang 19
New York 19
Millbury 18
Ottawa 17
Helsinki 15
Tokyo 15
Boston 14
Nanjing 13
Princeton 13
São Paulo 13
Council Bluffs 12
Dong Ket 12
Buffalo 11
Lawrence 11
Des Moines 10
Jacksonville 9
Phoenix 9
Redondo Beach 9
Mexico City 8
Montreal 8
Orem 8
Rome 8
Biên Hòa 7
Bratislava 7
Dallas 7
Frankfurt am Main 7
Seoul 7
Toronto 7
Bắc Giang 6
Mugnano Di Napoli 6
Ribeirão Preto 6
Nuremberg 5
Quito 5
Verona 5
Villaricca 5
Ankara 4
Baghdad 4
Bologna 4
Can Tho 4
Chennai 4
Houston 4
Hải Dương 4
Jiaxing 4
London 4
Motta di Livenza 4
Nanchang 4
Rio de Janeiro 4
Seattle 4
Stockholm 4
Tashkent 4
Thái Bình 4
Vienna 4
Aparecida de Goiânia 3
Atlanta 3
Bangkok 3
Belo Horizonte 3
Calgary 3
Caxias do Sul 3
Changsha 3
Denver 3
Dhaka 3
Fairfield 3
Falkenstein 3
Florence 3
Hebei 3
Jinan 3
Peruíbe 3
Poplar 3
Selargius 3
Shenyang 3
Tianjin 3
Vĩnh Long 3
Wilmington 3
Wuhan 3
Zhengzhou 3
Điện Bàn 3
Abidjan 2
Almaty 2
Amman 2
Avaré 2
Totale 2.040
Salva come PNG Salva come JPEG
Nome #
TAS2R38 genotype and CRS severity in children with cystic fibrosis 173
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR 162
A complicated association between two different genetic rare disorders: Cystic Fibrosis and Spinal Muscular Atrophy 158
Intra-individual biological variation in sweat chloride concentrations in CF, CFTR dysfunction, and healthy pediatric subjects 153
Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation 152
Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study 151
Serum and intestinal IGA anti-tissue transglutaminase antibodies in celiac children under 2 years of age. 146
Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. 141
Discriminant score for celiac disease based on immunohistochemical analysis of duodenal biopsies 136
Clinical, HLA and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. 135
Intestinal deposits of IgA anti tissue transglutaminase antibodies in celiac children under two years of age. 132
Potential celiac patients: a model of celiac disease pathogenesis. 132
Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1. 129
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 128
Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease. 127
Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study 126
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 126
Diabetes outbreak during COVID19 lock-down in a prediabetic patient with cystic fibrosis long treated with glargine. 125
A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres. 122
Non-invasive tools for detection of liver disease in children and adolescents with cystic fibrosis. 122
Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in celiac disease. 121
NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity 118
Elevated sweat chloride test: is it always cystic fibrosis 114
Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis 107
Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function. 106
Crellastatin A, a PARP-1 Inhibitor Discovered by Complementary Proteomic Approaches 89
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype 88
Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences 69
Hemoglobin Levels in Children Treated for Cystic Fibrosis with CFTR Modulators: A Single Center Retrospective Study 55
A Longitudinal Study of Glucose Tolerance in Cystic Fibrosis: The Central Role of Beta Cell Functional Mass 51
Blood platelet reduction after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis may depend on systemic inflammation reduction 50
Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in a Cystic Fibrosis Child With L1077P Mutation 31
Cystic fibrosis: New insights into therapeutic approaches 28
Repurposing therapies for the personalised treatment of cystic fibrosis 16
Mutation-specific therapies and drug repositioning in cystic fibrosis 12
Totale 3.831
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.100
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 1 13
2021/2022158 0 0 5 0 1 23 11 1 18 10 41 48
2022/2023309 24 9 9 13 47 32 0 36 75 50 11 3
2023/2024206 5 25 55 17 7 23 4 24 0 6 26 14
2024/2025995 46 63 2 9 48 45 77 77 67 78 389 94
2025/20261.940 185 180 190 176 363 70 190 121 304 116 45 0
Totale 3.831